Catheter Precision, Inc. 8-K

What Happened

• On June 7, 2026, Catheter Precision, Inc. announced it entered into a Securities Purchase Agreement to purchase 2,941,176 shares of Volato Group, Inc. at $0.34 per share for an aggregate subscription amount of $1,000,000 in a private placement. The closing is subject to customary conditions, including accuracy of representations, performance of covenants and absence of a Material Adverse Effect for Volato.
• As consideration for Catheter Precision’s participation, Volato agreed to deliver certain freely tradeable equity securities of a third-party entity (valued at approximately $1,100,000 as of June 5, 2026). The filing notes there is no guarantee the Company will realize the current market values through future sales.

Key Details

• Purchase: 2,941,176 Volato shares at $0.34 each; total $1,000,000 subscription amount.
• Market values (as of June 5, 2026): Volato shares aggregate ≈ $1,000,000; third‑party securities to be delivered ≈ $1,100,000.
• Closing conditions include standard reps/warranties, covenants and no Material Adverse Effect; closing is not automatic.
• Volato agreed to file a registration statement (Form S-3 or other appropriate form) to register resale of the shares within 10 calendar days and use best efforts to have it declared effective promptly.

Why It Matters

• This 8‑K reports Catheter Precision’s acquisition of an equity stake in another public company (Volato) and receipt of additional tradable securities, which creates cross‑holdings that may affect Catheter Precision’s investment portfolio and liquidity.
• The investment’s value is market‑driven and the filing expressly warns there is no guarantee the Company can realize the cited market values upon sale. The deal’s completion depends on customary closing conditions and the registration process, so investors should note the transaction is not yet closed.